MetabolicMounjaroZepbound

Tirzepatide

A dual GIP and GLP-1 receptor agonist researched for metabolic and weight outcomes.

Add to a stack

Half-life

~5 days

Schedule

weekly

Cycle

12–52 wks

Mechanism of action

Activates both GIP and GLP-1 receptors, with additive effects on insulin sensitivity, appetite and gastric emptying.

Potential applications

Glucose researchWeight research

Dosing information

Clinical research escalates dose gradually over many weeks.

For research and educational reference only — not a dosing recommendation.

Compatibility & stacks

Semaglutide

Both are incretin agonists with overlapping mechanism; concurrent use is not a studied combination.

Avoid

Aether Pulse provides educational and research information only. Content is not medical advice. Products are sold for research use only. Consult a qualified professional before making health decisions.